Biren K. Joshi

443 total citations
10 papers, 357 citations indexed

About

Biren K. Joshi is a scholar working on Pharmacology, Cell Biology and Analytical Chemistry. According to data from OpenAlex, Biren K. Joshi has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Cell Biology and 3 papers in Analytical Chemistry. Recurrent topics in Biren K. Joshi's work include Fungal Biology and Applications (6 papers), Plant Pathogens and Fungal Diseases (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Biren K. Joshi is often cited by papers focused on Fungal Biology and Applications (6 papers), Plant Pathogens and Fungal Diseases (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Biren K. Joshi collaborates with scholars based in United States, Spain and United Kingdom. Biren K. Joshi's co-authors include Donald T. Wicklow, James B. Gloer, Patrick F. Dowd, Bing Liu, Roman Davis, Authrine C. Whyte, Karen M. Alsante, Margaret S. Landis, Steven W. Baertschi and Mark H. Kleinman and has published in prestigious journals such as Applied and Environmental Microbiology, The Journal of Organic Chemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

Biren K. Joshi

10 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biren K. Joshi United States 8 158 142 107 64 63 10 357
Yicun Huang Singapore 11 162 1.0× 181 1.3× 147 1.4× 42 0.7× 88 1.4× 13 419
Ana Teran Spain 11 155 1.0× 133 0.9× 155 1.4× 77 1.2× 46 0.7× 15 405
Abdellatif Fkyerat France 11 151 1.0× 86 0.6× 213 2.0× 56 0.9× 99 1.6× 18 451
LAURETTA ZITANO United States 6 160 1.0× 194 1.4× 164 1.5× 30 0.5× 59 0.9× 6 395
Lisa Rahbæk Denmark 11 217 1.4× 174 1.2× 131 1.2× 47 0.7× 50 0.8× 17 448
Birgitte R. Rassing Denmark 11 169 1.1× 145 1.0× 107 1.0× 59 0.9× 62 1.0× 20 391
Ping Jiao United States 9 280 1.8× 188 1.3× 117 1.1× 31 0.5× 36 0.6× 14 489
Ines Kock Germany 9 102 0.6× 224 1.6× 88 0.8× 77 1.2× 49 0.8× 15 377
Sheng Lai Japan 13 214 1.4× 132 0.9× 66 0.6× 25 0.4× 38 0.6× 28 446
Klaus‐Dieter Menzel Germany 12 106 0.7× 232 1.6× 181 1.7× 45 0.7× 46 0.7× 17 400

Countries citing papers authored by Biren K. Joshi

Since Specialization
Citations

This map shows the geographic impact of Biren K. Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biren K. Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biren K. Joshi more than expected).

Fields of papers citing papers by Biren K. Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biren K. Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biren K. Joshi. The network helps show where Biren K. Joshi may publish in the future.

Co-authorship network of co-authors of Biren K. Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Biren K. Joshi. A scholar is included among the top collaborators of Biren K. Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biren K. Joshi. Biren K. Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Reynolds, Dan W., John M. Campbell, Biren K. Joshi, et al.. (2016). The Degradation Chemistry of Farglitazar and Elucidation of the Oxidative Degradation Mechanisms. Journal of Pharmaceutical Sciences. 106(4). 982–993. 3 indexed citations
3.
Cardellina, John H., Vicki A. Montgomery, Xin Hu, et al.. (2012). Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A. ACS Medicinal Chemistry Letters. 3(5). 387–391. 22 indexed citations
4.
Joshi, Biren K., et al.. (2010). Elucidating the Pathways of Degradation of Denagliptin. Journal of Pharmaceutical Sciences. 99(7). 3030–3040. 4 indexed citations
5.
Liu, Bing, et al.. (2002). Phosphine-Catalyzed Annulation of Thioamides and 2-Alkynoates:  A New Synthesis of Thiazolines. The Journal of Organic Chemistry. 67(13). 4595–4598. 65 indexed citations
6.
Joshi, Biren K., James B. Gloer, & Donald T. Wicklow. (2002). Bioactive Natural Products from a Sclerotium-Colonizing Isolate of Humicola fuscoatra. Journal of Natural Products. 65(11). 1734–1737. 42 indexed citations
7.
Whyte, Authrine C., Biren K. Joshi, James B. Gloer, Donald T. Wicklow, & Patrick F. Dowd. (2000). New Cyclic Peptide and Bisindolyl Benzenoid Metabolites from the Sclerotia of Aspergillus sclerotiorum. Journal of Natural Products. 63(7). 1006–1009. 18 indexed citations
8.
Joshi, Biren K., James B. Gloer, & Donald T. Wicklow. (1999). New Verticillin and Glisoprenin Analogues from Gliocladium catenulatum, a Mycoparasite of Aspergillus flavus Sclerotia. Journal of Natural Products. 62(5). 730–733. 37 indexed citations
9.
Joshi, Biren K., James B. Gloer, Donald T. Wicklow, & Patrick F. Dowd. (1999). Sclerotigenin:  A New Antiinsectan Benzodiazepine from the Sclerotia of Penicillium sclerotigenum. Journal of Natural Products. 62(4). 650–652. 63 indexed citations
10.
Wicklow, Donald T., et al.. (1998). Antifungal Metabolites (Monorden, Monocillin IV, and Cerebrosides) from Humicola fuscoatra Traaen NRRL 22980, a Mycoparasite of Aspergillus flavus Sclerotia. Applied and Environmental Microbiology. 64(11). 4482–4484. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026